A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection
Clinical trial NCT05831189 · COMPLETED
Trial details
- NCT number
- NCT05831189
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-21
- Primary completion
- 2025-01-17
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.